Capturing information about drug resistance vs sensitive cancers and direct comparison of FOXO3-FOXM1 axis with drug transporters would provide better understanding of chemoresistance mechanisms in colon cancer. This evidence concerns the gene FOXM1 and malignant colon neoplasm.